Literature DB >> 11476414

Setting the benchmark for research in the management of acute pain in emergency departments.

A M Kelly1.   

Abstract

OBJECTIVE: The aim of this study was to define the degree of change on a visual analogue scale that corresponded to a clinically meaningful reduction in the level of pain reported by patients experiencing acute pain.
METHOD: Secondary analysis of data was performed from prospective, descriptive studies of 152 adults and 73 children presenting to emergency departments with acute pain. At presentation and at 20 min intervals to a maximum of three measurements, patients marked the level of their pain on a 100 mm, non-hatched visual analogue scale. At each follow up, they also gave a verbal rating of their pain as 'a lot better', 'a little better', 'much the same', 'a little worse' or 'much worse'. Data from the groups reporting that pain was 'a lot better' and 'about the same' were analysed for mean and median absolute change in visual analogue scale and compared.
RESULTS: Of 559 pain comparisons, 60 were rated as 'a lot better' and 257 as 'about the same'. The mean absolute change in visual analogue scale for the group reporting that pain was 'a lot better' was 24 mm (median = 19 mm, 95% confidence interval = 17-31 mm). For the group reporting that pain was 'about the same', the mean visual analogue scale change was 0 mm (median = 0 mm, 95% confidence interval = -1 to 1 mm).
CONCLUSION: When evaluating treatments for acute pain, a difference in visual analogue scale pain score of less than about 20 mm is unlikely to be clinically meaningful. Studies should be designed and reported relative to this benchmark rather than the minimum clinically significant difference in visual analogue scale pain score.

Entities:  

Mesh:

Year:  2001        PMID: 11476414     DOI: 10.1046/j.1442-2026.2001.00179.x

Source DB:  PubMed          Journal:  Emerg Med (Fremantle)        ISSN: 1035-6851


  9 in total

Review 1.  Children's self-reports of pain intensity: scale selection, limitations and interpretation.

Authors:  Carl L von Baeyer
Journal:  Pain Res Manag       Date:  2006       Impact factor: 3.037

2.  Effect of Oral Prednisolone after Collagenase Injection for Dupuytren's Contracture: A Randomized, Controlled Trial with a 1-Year Follow-Up.

Authors:  Yoshihiro Abe
Journal:  J Hand Microsurg       Date:  2020-04-13

3.  The effect of vapocoolant spray on pain due to intravenous cannulation in children: a randomized controlled trial.

Authors:  Ken J Farion; Karen L Splinter; Kym Newhook; Isabelle Gaboury; William M Splinter
Journal:  CMAJ       Date:  2008-07-01       Impact factor: 8.262

4.  Comparisons between the efficacy of limaprost alfadex and pregabalin in cervical spondylotic radiculopathy : design of a randomized controlled trial.

Authors:  Akira Onda; Masashi Kimura
Journal:  Fukushima J Med Sci       Date:  2018-07-14

5.  Troxipide in the management of gastritis: a randomized comparative trial in general practice.

Authors:  Bhupesh Dewan; Aarthi Balasubramanian
Journal:  Gastroenterol Res Pract       Date:  2010-11-25       Impact factor: 2.260

Review 6.  Pain relief that matters to patients: systematic review of empirical studies assessing the minimum clinically important difference in acute pain.

Authors:  Mette Frahm Olsen; Eik Bjerre; Maria Damkjær Hansen; Jørgen Hilden; Nino Emanuel Landler; Britta Tendal; Asbjørn Hróbjartsson
Journal:  BMC Med       Date:  2017-02-20       Impact factor: 8.775

7.  A week of pain in the emergency department.

Authors:  Hilary Sarah Thornton; Joseph Reynolds; Timothy J Coats
Journal:  Br J Pain       Date:  2017-09-19

8.  Validation of the Hanyang Pain Scale for clerical workers with musculoskeletal pain.

Authors:  Ki Young Oh
Journal:  J Pain Res       Date:  2016-04-08       Impact factor: 3.133

9.  Dynamics of quality of life improvement after floppy Nissen fundoplication for gastroesophageal reflux disease.

Authors:  Jarek Kobiela; Łukasz Kaska; Magdalena Pindel; Arkadiusz Szarmach; Maria Janiak; Monika Proczko-Markuszewska; Tomasz Stefaniak; Dariusz Łaski; Andrzej Łachiński; Zbigniew Śledziński
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2015-09-16       Impact factor: 1.195

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.